COVID-19 Susceptibility in Bronchial Asthma

BACKGROUND: Bronchial asthma has not been adequately assessed in coronavirus disease 2019 (COVID-19). Respiratory allergy is associated with significant reductions in the expression of angiotensin-converting enzyme 2 receptor, which is the entry receptor for COVID-19. OBJECTIVE: To observe COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, Ilan, Merzon, Eugene, Vinker, Shlomo, Golan-Cohen, Avivit, Magen, Eli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683297/
https://www.ncbi.nlm.nih.gov/pubmed/33242628
http://dx.doi.org/10.1016/j.jaip.2020.11.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683297/
https://www.ncbi.nlm.nih.gov/pubmed/33242628
http://dx.doi.org/10.1016/j.jaip.2020.11.020

Ejemplares similares